Gene | Allele | Assay Type | Description |
---|---|---|---|
D11Nds3 | PCR amplified length variant | Todd, unpublished | |
Slc2a4 | PCR amplified length variant | Glut-4 primers | |
Trp53 | PCR amplified length variant | Cornall, et al., Genomics 10:874-881, 1991 | |
D11Nds18 | PCR amplified length variant | Burns, et al., Oncogene 6:2363-2369, 1991 | |
D11Nds16 | PCR amplified length variant | Burns, et al., Oncogene 6:2363-2369, 1991 | |
D11Nds1 | PCR amplified length variant | Love, et al., Nucleic Acids Res 18:4123-4130, 1990 | |
Evi2a | PCR amplified length variant | Evi-2 primers | |
D11Nds17 | PCR amplified length variant | Hearne, Mamm Genome 1:273-282, 1991 | |
D11Nds5 | PCR amplified length variant | Love, et al., Nucleic Acids Res 18:4123-4130, 1990 | |
D11Nds15 | PCR amplified length variant |
Marker 1 | Marker 2 | # Recombinants | # Parentals |
---|---|---|---|
D11Nds3 | Slc2a4 | 13 | 66 |
Slc2a4 | Trp53 | 0 | 145 |
Trp53 | D11Nds18 | 3 | 213 |
D11Nds18 | D11Nds16 | 1 | 211 |
D11Nds16 | D11Nds1 | 2 | 213 |
D11Nds1 | Evi2a | 3 | 211 |
Evi2a | D11Nds17 | 9 | 200 |
D11Nds17 | D11Nds5 | 9 | 54 |
D11Nds5 | D11Nds15 | 4 | 58 |
Marker 1 | Marker 2 | # Recombinants | Total | % Recombinants | Std Error |
---|---|---|---|---|---|
D11Nds1 | Evi2a | 3 | 214 | 1.402 | 0.804 |
D11Nds16 | D11Nds1 | 2 | 215 | 0.930 | 0.655 |
D11Nds17 | D11Nds5 | 9 | 63 | 14.286 | 4.409 |
D11Nds18 | D11Nds16 | 1 | 212 | 0.472 | 0.471 |
D11Nds3 | Slc2a4 | 13 | 79 | 16.456 | 4.172 |
D11Nds5 | D11Nds15 | 4 | 62 | 6.452 | 3.120 |
Evi2a | D11Nds17 | 9 | 209 | 4.306 | 1.404 |
Slc2a4 | Trp53 | 0 | 145 | 0.000 | 0.000 |
Trp53 | D11Nds18 | 3 | 216 | 1.389 | 0.796 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|